This is a service of EIN News a digital news provider
Healthcare Industry Today
Sign up for a free trial
Register Now
Member center Log In
Telmisartan News is an EIN News Service for health professionals. Constantly updated news and information about health.
FORMATS: RSS | EMAIL

Latest Telmisartan News

Sort by: relevance (24 hours) relevance date
  • Istodax Approved for Cutaneous T-Cell Lymphoma 7 Nov 2009 00:53 GMT
    ... FDA notified consumers that Stiff Nights, a product ... is a kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma. ...

  • Bad-Behaving Teens May Be Living Up to Expectations 7 Nov 2009 15:52 GMT
    ... FDA notified consumers that Stiff Nights, a product ... a histone deacetylase (HDAC) inhibitor indicated the treatment of cutaneous T-cell lymphoma. Cervarix (human papillomavirus ...

  • Clinical Trials Update: Nov. 5, 2009 5 Nov 2009 18:33 GMT
    ... Bodybuilding.com and FDA notified healthcare professionals and patients ... information for Byetta (exenatide) to include... Qualitest Pharmaceuticals and FDA notified healthcare professionals of a ... is a kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma. ...

  • Clinical Trials Update: Nov. 3, 2009 3 Nov 2009 18:52 GMT
    ... FDA notified healthcare professionals of revisions to the prescribing ... information for Byetta (exenatide) to include... Qualitest Pharmaceuticals and FDA notified healthcare professionals of a ... is a kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma. ...

  • Clinical Trials Update: Nov. 4, 2009 4 Nov 2009 18:13 GMT
    ... FDA notified healthcare professionals of revisions to the prescribing ... information for Byetta (exenatide) to include... Qualitest Pharmaceuticals and FDA notified healthcare professionals of a ... is a kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma. ...

  • Clinical Trials Update: Nov. 2, 2009 2 Nov 2009 18:52 GMT
    ... Qualitest Pharmaceuticals and FDA notified healthcare professionals of a ... is a kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma. ...

  • Doctors Point Out Gaps in U.S. Health Care 5 Nov 2009 18:33 GMT
    ... Bodybuilding.com and FDA notified healthcare professionals and patients ... information for Byetta (exenatide) to include... Qualitest Pharmaceuticals and FDA notified healthcare professionals of a ... is a kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma. ...

  • FDA Issues Warning for Diabetes Drug 3 Nov 2009 18:52 GMT
    ... FDA notified healthcare professionals of revisions to the prescribing ... information for Byetta (exenatide) to include... Qualitest Pharmaceuticals and FDA notified healthcare professionals of a ... is a kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma. ...

  • Drug Could Help Treat Small HER2-Positive Breast Tumors 3 Nov 2009 18:52 GMT
    ... FDA notified healthcare professionals of revisions to the prescribing ... information for Byetta (exenatide) to include... Qualitest Pharmaceuticals and FDA notified healthcare professionals of a ... is a kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma. ...

  • FDA Initiative Seeks to Reduce Accidental Overdoses 4 Nov 2009 22:53 GMT
    ... Bodybuilding.com and FDA notified healthcare professionals and patients ... information for Byetta (exenatide) to include... Qualitest Pharmaceuticals and FDA notified healthcare professionals of a ... is a kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma. ...

  • Clinical Trials Update: Nov. 6, 2009 6 Nov 2009 18:32 GMT
    ... FDA notified consumers that Stiff Nights, a product ... is a kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma. ...

  • Graceway Pharmaceuticals Acquires Worldwide Rights to GS 9191 from Gilead Sciences 6 Nov 2009 18:32 GMT
    ... FDA notified consumers that Stiff Nights, a product ... is a kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma. ...

  • Gene Discovery Gives Clues to Crohn's Disease, Colitis 5 Nov 2009 00:13 GMT
    ... Bodybuilding.com and FDA notified healthcare professionals and patients ... information for Byetta (exenatide) to include... Qualitest Pharmaceuticals and FDA notified healthcare professionals of a ... is a kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma. ...

  • Green Tea May Help Prevent Oral Cancer 5 Nov 2009 15:53 GMT
    ... Bodybuilding.com and FDA notified healthcare professionals and patients ... information for Byetta (exenatide) to include... Qualitest Pharmaceuticals and FDA notified healthcare professionals of a ... is a kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma. ...

  • Without Job Stress, Retirees Sleep Better 5 Nov 2009 15:53 GMT
    ... Bodybuilding.com and FDA notified healthcare professionals and patients ... information for Byetta (exenatide) to include... Qualitest Pharmaceuticals and FDA notified healthcare professionals of a ... is a kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma. ...


1 - 15 / 79      NEXT >>>

Powered by Newsfeed Maker
NOT SATISFIED WITH THIS TELMISARTAN NEWS SECTION? MAKE YOUR OWN WITH THE INBOX ROBOT OR TRY OUR OTHER MEDIA MONITORING SERVICES.
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>
 
 

Take This Poll

According to the White House, 650,000 jobs were created or saved by $150 billion in stimulus funds. Was it money well spent? (Oct. 30, 2009)



 

BUSINESS PROMOTION SERVICES

EIN Advertising · Place banner ads on EIN News industry specific publications.

EIN Presswire · Upload press releases to the EIN network and have them submitted to leading journalists and decision-makers worldwide.

EIN Global Events · Reach industry-specific readers and promote events, conferences or exhibitions.

EIN Business Directory · Present company or service information on highly-visible, industry and geo-specific news pages.

NEWS SERVICES

News Publications · In-depth geopolitical and industry specific news coverage aggregated from 35,000 online outlets. Updated every 15 minutes.

News Alerts · Receive a free selection of the day's top stories hand picked by EIN News editors.

Newsfeed Maker · Integrate customized newsfeeds in any format covering all industry and geopolitical topics, updated every 15 minutes.

EIN Presswire · Upload press releases to the EIN network and have them submitted journalists and decision-makers worldwide.

Inbox Robot · Customized newsletters delivered by e-mail. Search a news index monitoring thousands of trusted media sources.

COMPANY BACKGROUND

About EIN News · Established in 1995, EIN News began by supplying business professionals and individuals with relevant and interesting news products. It has grown to become the largest digital news provider in Europe.

Member List · See the partial member list and join a community of professionals from private industry, institutions, and governments that rely on EIN as a critical source for research, breaking news and media services.